Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

STAT+: What to expect from UniQure’s upcoming Huntington’s gene therapy readout

Before the end of September, UniQure is expected to report four-year results from the closely tracked clinical trial of its gene therapy for Huntington’s disease.

STAT+: What to expect from UniQure’s upcoming Huntington’s gene therapy readout

We haven't written up this one. STAT News has the full story — the link below goes straight to it.

Read the original at statnews.com →

More in Health & Medicine

More from Thursday 10 September →